A call for global gender neutral HPV vaccination
A new approach to HPV
prevention policy
We have the means to protect everyone
We have the means to protect everyone – whatever their sex or gender – from high-risk HPV infections and the cancers they cause. To achieve this, a more ambitious, ethical and equitable approach to HPV vaccination is needed at the global and national levels.
End HPV Global is a partnership between two leading health initiatives
GAMH brings together organisations worldwide around men's health advocacy, working toward a world where every all men and boys have the opportunity to achieve their best possible health, regardless of location or background.
Founded by three siblings after losing their mother to HPV-caused cancer, NOMAN advocates, educates, and builds coalitions worldwide, urging policymakers that gender-neutral HPV vaccination is the only path to elimination.
Our Recommendations
01
HPV must be understood
HPV must be understood, and responded to, as a threat to the health of all sexes and genders.
02
Eliminate high-risk types
GNV should be viewed from the perspective of its potential to eliminate high-risk, oncogenic HPV types, thereby accelerating the elimination of not only cervical cancer but also all the cancers caused by HPV.
03
Make boys a primary target for vaccination
By 2028, global policymakers should have reviewed the issue of GNV with a view to recommending its implementation. WHO should make boys a primary target for HPV vaccination.
04
Gender-neutral vaccination
By 2030, all countries currently without an HPV vaccination programme should have introduced HPV vaccination on a gender-neutral basis while countries currently with a girls-only programme should have transitioned to GNV.
05
Health partnerships between countries
Health partnerships between countries with established GNV programmes and lower-income countries should be established along with capacity-building initiatives to support the wider implementation of GNV.
06
Focus on increasing vaccine uptake
A greater focus is needed on increasing vaccine uptake to at least 90% for all, a target most likely to be achieved through school-based vaccination programmes.
